Proteos - alpha-synuclein shipments 2017

Supporting Global Efforts for Parkinson’s Disease Research


Proteos has proudly partnered with The Michael J. Fox Foundation to provide high-quality protein reagents to support Parkinson’s disease research.  In the past 9 months (September 2016 to June 2017), we have delivered protein reagents to 22 U.S. and 19 international locations in support of this research effort.

Tags: Alpha-synuclein, MJFF, Parkinson's Disease, protein shipments

Alpha-synuclein Research Tools poster co-authored by Lindsey Gottler, PhD., Proteos’ Director of Protein Purification


The Michael J. Fox Foundation's Strategy to Generate, Characterize, and Distribute Preclinical Alpha-Synuclein Research Tools for Molecular Biology presented at Neuroscience 2016.

Tags: Alpha-synuclein, MJFF, Parkinson's

New Alpha-synuclein Filament-specific Antibody


Now available from the MJFF Research Tools Program is a conformation-specific rabbit monoclonal antibody raised against filament alpha-synuclein, which recognizes both oligomeric and filamentous alpha-synuclein. This project was done in partnership with Proteos, Inc.; Abcam; and Aarhus University.

New Alpha-synuclein Proteins Available

Tags: Alpha-synuclein, MJFF

Commercial Launch of Human Alpha-synuclein Proteins


MJFF announced the commercial launch of human alpha-synuclein proteins including monomeric and filament versions, as well as protocols and specially formulated monomeric alpha-synuclein to generate pre-formed fibrils. This project was in partnership with Proteos, Inc., and the proteins were validated by the Jensen and Luk laboratories at Aarhus University and the University of Pennsylvania, respectively.

Tags: Alpha-synuclein, MJFF

Customize This